Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Mon, Dec 15, 2025 08:45 AM All times are UTC

Follow Series

©Econometrics LLC . All Rights Reserved.

Allen Cheng

Professor in Infectious Diseases Epidemiology, Monash University
Allen Cheng is a specialist in infectious diseases and an epidemiologist. He is Professor/Director of Infectious Diseases at Monash Health and the School of Clinical Sciences at Monash University in Melbourne, and is involved in the treatment of patients with infectious diseases, and providing advice to governments on communicable diseases control. He is also involved in in surveillance for influenza-related hospital admissions through the FluCAN system, based at 21 hospitals nationally. He was previously Deputy Victorian Chief Health Officer, and a past Co-Chair of the Australian Technical Advisory Group on Immunisation and the Advisory Committee for Vaccines.

Better cleaning of hospital equipment could cut patient infections by one-third – and save money

Apr 12, 2025 09:57 am UTC| Insights & Views Business

Hospital-acquired infections are infections patients didnt have when they were admitted to hospital. The most common include wound infections after surgery, urinary tract infections and pneumonia. These can have a big...

What pathogen might spark the next pandemic? How scientists are preparing for ‘disease X’

Sep 29, 2024 10:14 am UTC| Health

Before the COVID pandemic, the World Health Organization (WHO) had made a list of priority infectious diseases. These were felt to pose a threat to international public health, but where research was still needed to...

The rise and fall of antibiotics. What would a post-antibiotic world look like?

Nov 08, 2023 12:00 pm UTC| Health

Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversations experts explore how we got here and the potential solutions. These days, we dont...

Economy

Asian Technology and Chipmaking Stocks Slide as AI Spending Concerns Shake Markets

Asian technology and chipmaking stocks fell sharply on Monday as investor caution intensified over growing uncertainties surrounding artificial intelligence (AI) spending and its impact on future earnings. The sell-off...

China’s November Economic Data Signals Slowing Industrial Output and Weak Consumer Demand

Chinas economic momentum showed further signs of strain in November as key indicators pointed to slower growth in industrial output and a sharper-than-expected slowdown in consumer spending, according to official data...

Oil Prices Rebound as U.S.-Venezuela Tensions Offset Oversupply Concerns

Oil prices edged higher on Monday, recovering part of last weeks sharp decline, as rising geopolitical tensions between the United States and Venezuela fueled concerns over potential supply disruptions. These worries...

Dollar Struggles as Markets Eye Key Central Bank Decisions and Global Rate Outlooks

The U.S. dollar remained under pressure on Monday, extending losses near a two-month low, while the euro and British pound held relatively steady as investors awaited a series of critical central bank decisions this week....

Asian Stocks Slide as Central Bank Decisions and Key Data Keep Investors Cautious

Asian stock markets opened the week lower as investors reduced risk exposure amid thin year-end liquidity, looming central bank decisions, and a packed schedule of delayed economic data releases. Early Monday trading saw...

Politics

Special Prosecutor Alleges Yoon Suk Yeol Sought North Korea Provocation to Justify Martial Law

A South Korean special prosecutor has accused former President Yoon Suk Yeol of attempting to provoke North Korea into an armed confrontation as part of an alleged plot to justify the declaration of martial law in December...

Supporters Gather Ahead of Verdict in Jimmy Lai’s Landmark Hong Kong National Security Trial

Supporters of Hong Kong democracy activist and media tycoon Jimmy Lai queued overnight outside the citys High Court on Monday as anticipation grew ahead of the verdict in his landmark national security trial, a case that...

Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership

Korea Zincs board is set to convene on Monday to vote on a major overseas investment plan that could significantly strengthen the supply chain for critical minerals in the United States. According to a source familiar with...

Hong Kong Democratic Party Disbands After Member Vote Amid Security Crackdown

Hong Kongs last major opposition party, the Democratic Party, has voted to disband, marking a significant moment in the citys political history and underscoring the impact of Chinas national security crackdown on liberal...

Ukraine’s NATO Concession Unlikely to Shift Peace Talks, Experts Say

Ukraines recent offer to abandon its long-standing ambition to join NATO is unlikely to have a major impact on ongoing peace talks with Russia, according to several foreign policy and security experts. During discussions...

Science

Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman

The U.S. Senate Commerce Committee announced it will vote on December 8 on President Donald Trumps renewed nomination of private astronaut and tech entrepreneur Jared Isaacman to lead NASA. Isaacman, known for his...

NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead

NASA has significantly scaled back Boeings Starliner program after years of technical issues and delays, announcing that the next Starliner mission to the International Space Station (ISS) will fly without astronauts. The...

Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission

Blue Origins massive New Glenn rocket marked a major milestone as it completed its first mission for paying customers, sending two NASA satellites toward Mars and successfully landing its reusable booster at sea. The...

Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment

Cogent Biosciences (NASDAQ: COGT) shares skyrocketed over 120% after the biotech company announced groundbreaking results from its Phase 3 PEAK trial evaluating bezuclastinib in combination with sunitinib for patients with...

Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage

U.S. President Donald Trump and German pharmaceutical company Merck KGaA have announced a groundbreaking deal aimed at lowering the cost of in-vitro fertilization (IVF) treatments while boosting access to fertility care in...

Technology

iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures

iRobot, the company behind the popular Roomba robotic vacuum cleaner, has filed for Chapter 11 bankruptcy protection in the United States as it prepares to go private through an acquisition by Picea Robotics, its primary...

Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges

Nvidia is evaluating whether to expand production capacity for its powerful H200 artificial intelligence chips after demand from Chinese customers significantly exceeded current supply, according to multiple sources...

SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles

SpaceX has reportedly begun the early stages of preparing for a potential initial public offering (IPO), marking a significant milestone for the private aerospace company founded by Elon Musk. According to a report from...

SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation

SpaceX, the aerospace company founded by Elon Musk, has reportedly authorized an insider share sale that places its valuation at approximately $800 billion, according to a Bloomberg News report published Friday. The move...

Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand

Mizuho Securities has raised its price target on Broadcom Inc. (NASDAQ: AVGO), highlighting accelerating momentum in the companys artificial intelligence business and a rapidly expanding long-term backlog. The brokerage...